Health News Archive

Enter a date to view that day's archives:

Showing 1-20 of 251 stories from the past year.

Targazyme, Inc. (formerly America Stem Cell Inc.), a clinical-stage biopharmaceutical company, received a Small Business Innovation Research award to fund the development of genetically-modified mesenchymal stem cells treated with Targazyme's lead product, TZ101, for treatment of oral mucositis.

Kaiser Permanente is adding to its San Diego portfolio with the new San Diego Central Hospital in Kearny Mesa.

In a move to expand its efforts in translational medicine, the University of California San Diego is building a new facility for its Clinical and Translational Research Institute.

Poseidon Water, which is developing in Carlsbad what will be the largest seawater desalination plant in the Western Hemisphere, is contracted to have the plant running by late November 2015.

Sharp Grossmont Hospital’s new Heart and Vascular Center is about 30 percent complete and on schedule to open for patients in spring 2015, according to Sharp HealthCare officials. The three-story, 71,000-square-foot facility is part of Sharp Grossmont’s master site plan to expand and enhance the campus.

An assisted-living facility catering to those with memory loss-related diseases is under construction in San Diego.

Construction on the Scripps Prebys Cardiovascular Institute, which began in June 2011, is nearing completion. The facility, being developed by Scripps Health, is expected to be open for patient care by spring of 2015.

The Otay Water District is in the process of getting final permitting and an environmental impact review approved to construct a new pipeline system to receive water from a future desalination plant in Mexico.

Construction is complete on the first of the two-phase, award-winning Las Colinas Detention and Reentry Facility in Santee.


Sorrento Therapeutics Inc. (Nasdaq: SRNE) received funding from the National Institutes of Health to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 (WISP1) for the potential treatment of idiopathic pulmonary fibrosis, which affects more than 100,000 Americans.


The Salk Institute for Biological Studies raised nearly $68 million during fiscal year 2014 in support of its first-ever capital fundraising campaign, The Campaign for Salk.


The San Diego Center for Children has named Moisés Barón its new CEO.


A new medical office building developed and owned by Family Health Centers of San Diego has been completed in the Chollas View neighborhood of San Diego.

Researchers at the Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick are planning a study on an experimental drug that was given to two American aid workers to treat the Ebola virus.

National City's Geneva Healthcare, the developer of a technology platform for managing data for cardiac devices, has raised $1.83 million in its first round of financing to expand its reach to hospital systems and health care networks nationwide.


The Scripps Research Institute board of trustees announced Tuesday that James Paulson, chair of the department of cell and molecular biology, has been appointed acting president and CEO.

Qualcomm Inc. (Nasdaq: QCOM) announced Tuesday that its subsidiary Qualcomm Life Inc. is collaborating with ResMed (NYSE: RMD), King's Daughters Medical Center and CareCentrix to develop next-generation connected health solutions.

The Wellcome Trust Sanger Institute, a genome center located near Cambridge, U.K., has purchased an Irys System from San Diego-based BioNano Genomics.

San Diego-based Trovagene Inc. (Nasdaq: TROV), a developer of cell-free molecular diagnostics, announced Tuesday that K. Peter Hirth, Ph.D., has joined the company's scientific advisory board.


On Saturday, Aug. 16, Family Health Centers of San Diego will present its eighth annual family health and fitness fair ¡Vive tu vida! Get Up! Get Moving!

Subscribe Today!